Portfolio company
Nectero
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Nectero develops endovascular systems to stabilise small to mid-sized abdominal aortic aneurysms for patients who are not yet candidates for surgery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Vesteck
Vesteck develops endovascular suture delivery catheters for surgeons to secure grafts and improve outcomes for aortic aneurysm patients during repair procedures.
Endoron Medical
This company develops a catheter-based stapling system for the fixation and sealing of endografts used in the endovascular repair of abdominal aortic aneurysms.
Aortyx
This company develops bioresorbable endovascular patches and catheter delivery systems for surgeons to treat patients with aortic dissection and other vascular diseases.
Ictero Medical
This company develops a minimally invasive gallbladder ablation system to treat gallstone disease in patients who wish to avoid traditional surgery.
Append Medical
The company develops a transcatheter system for left atrial appendage elimination to prevent strokes in patients with atrial fibrillation without leaving permanent metal implants.
OctoVascular
OctoVascular develops automated vessel connection technology for surgeons to perform minimally invasive coronary artery bypass surgery.
Nitiloop
Nitiloop develops vascular microcatheters for cardiologists and surgeons to treat chronic total occlusions and other complex lesions within coronary and peripheral vasculature.
TripleMed
This medical technology company develops injectable polymer solutions to treat and prevent aortic aneurysms for surgeons and hospitals.